AMDEV LYTENING 2Z SODIUM/POTASSIUM/LITHIUM ANALYZE— 510(k) K895465

Substantially Equivalent

Baxter Healthcare Corp

FDA 510(k) clearance K895465 for AMDEV LYTENING 2Z SODIUM/POTASSIUM/LITHIUM ANALYZE, Substantially Equivalent on 1989-12-27. Applicant: Baxter Healthcare Corp.

Clearance details

Applicant: Baxter Healthcare Corp
Product code: Code JIH
Advisory panel: Clinical Toxicology
Date received: 1989-09-11
Decision date: 1989-12-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Santa Ana, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.